EP1961820 - Vaccine composition comprising LAGE-1 tumor associated nucleic acids or LAGE-1 polypeptides [Right-click to bookmark this link] | |||
Former [2008/35] | Lage-1 tumor associated nucleic acids | ||
[2012/17] | Status | No opposition filed within time limit Status updated on 04.10.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 17.07.2015 | Lapse of the patent in a contracting state New state(s): LU | published on 19.08.2015 [2015/34] | Applicant(s) | For all designated states Ludwig Institute for Cancer Research Ltd 666 Third Avenue, 28th Floor New York, NY 10017 / US | [2012/48] |
Former [2008/35] | For all designated states LUDWIG INSTITUTE FOR CANCER RESEARCH 605 Third Avenue New York New York 10158 / US | Inventor(s) | 01 /
Lethe, Bernard Institute Ludwig pour la Rechercher sue le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | 02 /
Lucas, Sophie Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | 03 /
de Smet, Charles Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | 04 /
Godelaine, Daniele Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | 05 /
Boon-Falleur, Thierry Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | [2012/48] |
Former [2008/35] | 01 /
Lethe, Bernard Institute Ludwig pour la Rechercher sue le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | ||
02 /
Lucas, Sophie Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | |||
03 /
de Smet, Charles Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | |||
04 /
Godelaine, Daniele Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | |||
05 /
Boon-Falleur, Thierry Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE | Representative(s) | Gill, Siân Victoria, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2013/30] |
Former [2008/35] | Furlong, Isla Jane, et al Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge CB4 0WZ / GB | Application number, filing date | 08154900.8 | 27.01.1998 | [2008/35] | Priority number, date | US19970791495 | 27.01.1997 Original published format: US 791495 | [2008/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1961820 | Date: | 27.08.2008 | Language: | EN | [2008/35] | Type: | A3 Search report | No.: | EP1961820 | Date: | 24.12.2008 | [2008/52] | Type: | B1 Patent specification | No.: | EP1961820 | Date: | 28.11.2012 | Language: | EN | [2012/48] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.11.2008 | Classification | IPC: | A61K39/00, C07K14/705, C07K14/47 | [2012/17] | CPC: |
C07K14/70539 (EP);
C07K14/4748 (EP);
A61K2039/51 (EP);
A61K38/00 (EP);
A61K39/00 (EP)
|
Former IPC [2008/35] | C12N15/12, C07K14/705, C07K16/18, C12Q1/68, A61K38/17, // C12N15/11, A61K48/00 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2008/35] | Title | German: | Impfstoffzusammensetzung welche LAGE-1-Tumor-assoziierte Nukleinsäuren oder LAGE-1 Polypeptide enthält | [2012/17] | English: | Vaccine composition comprising LAGE-1 tumor associated nucleic acids or LAGE-1 polypeptides | [2012/17] | French: | Composition vaccinale comprenant des acides nucléiques LAGE-1 associés aux tumeurs ou des polypeptides LAGE-1 | [2012/17] |
Former [2008/35] | LAGE-1-Tumor-assoziierte Nukleinsäuren | ||
Former [2008/35] | Lage-1 tumor associated nucleic acids | ||
Former [2008/35] | Acides nucléiques associés à la tumeur LAG-1 | Examination procedure | 04.03.2009 | Amendment by applicant (claims and/or description) | 26.05.2009 | Examination requested [2009/27] | 10.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 20.12.2010 | Reply to a communication from the examining division | 19.04.2012 | Communication of intention to grant the patent | 08.08.2012 | Fee for grant paid | 08.08.2012 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP98903726.2 / EP0970206 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980903726) is 29.01.2002 | Opposition(s) | 29.08.2013 | No opposition filed within time limit [2013/45] | Fees paid | Renewal fee | 21.04.2008 | Renewal fee patent year 03 | 21.04.2008 | Renewal fee patent year 04 | 21.04.2008 | Renewal fee patent year 05 | 21.04.2008 | Renewal fee patent year 06 | 21.04.2008 | Renewal fee patent year 07 | 21.04.2008 | Renewal fee patent year 08 | 21.04.2008 | Renewal fee patent year 09 | 21.04.2008 | Renewal fee patent year 10 | 21.04.2008 | Renewal fee patent year 11 | 20.01.2009 | Renewal fee patent year 12 | 19.01.2010 | Renewal fee patent year 13 | 28.01.2011 | Renewal fee patent year 14 | 30.01.2012 | Renewal fee patent year 15 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | DK | 28.11.2012 | FI | 28.11.2012 | IT | 28.11.2012 | SE | 28.11.2012 | LU | 27.01.2013 | MC | 31.01.2013 | GR | 01.03.2013 | ES | 11.03.2013 | PT | 28.03.2013 | DE | 01.08.2013 | [2015/34] |
Former [2013/48] | DK | 28.11.2012 | |
FI | 28.11.2012 | ||
IT | 28.11.2012 | ||
SE | 28.11.2012 | ||
MC | 31.01.2013 | ||
GR | 01.03.2013 | ||
ES | 11.03.2013 | ||
PT | 28.03.2013 | ||
DE | 01.08.2013 | ||
Former [2013/37] | DK | 28.11.2012 | |
FI | 28.11.2012 | ||
IT | 28.11.2012 | ||
SE | 28.11.2012 | ||
MC | 31.01.2013 | ||
GR | 01.03.2013 | ||
ES | 11.03.2013 | ||
PT | 28.03.2013 | ||
Former [2013/34] | DK | 28.11.2012 | |
FI | 28.11.2012 | ||
SE | 28.11.2012 | ||
GR | 01.03.2013 | ||
ES | 11.03.2013 | ||
PT | 28.03.2013 | ||
Former [2013/28] | FI | 28.11.2012 | |
SE | 28.11.2012 | ||
GR | 01.03.2013 | ||
ES | 11.03.2013 | ||
PT | 28.03.2013 | ||
Former [2013/24] | FI | 28.11.2012 | |
SE | 28.11.2012 | ||
GR | 01.03.2013 | ||
ES | 11.03.2013 | ||
Former [2013/22] | FI | 28.11.2012 | |
SE | 28.11.2012 | ||
ES | 11.03.2013 | ||
Former [2013/21] | SE | 28.11.2012 | Documents cited: | Search | [DA]WO9220356 (LUDWIG INST CANCER RES [US]); | [E]WO9814464 (LUDWIG INST CANCER RES [US]); | by applicant | WO9204381 | WO9220356 | US5342774 | WO9500654 | US5399346 | US5405940 | WO9610577 | US5571711 | US5587289 | US5589334 | US5610013 | US5620886 | US5683886 | US5804381 | US5821122 | US5939526 | US5997870 | US19920994928 | US19930008446 | US19930096039 | US19950408015 | US19950530015 |